MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx in recurrent pericarditis is fully funded through to a planned New Drug Application…
Author
admin
-
-
-
This week was marked by strong, event-driven volatility across the tech sector. Market moves were shaped by artificial intelligence (AI) infrastructure announcements, semiconductor…
-
Investing
Finlay Minerals Announces Closing of Non-Brokered Private Placement of Flow-Through and Non-Flow-Through Units
by admin/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ finlay minerals ltd. (TSXV: FYL,OTC:FYMNF) (OTCQB: FYMNF) (‘Finlay’ or the ‘Company’)…
-
-
-
-
-
-
